Search
for
Sort by
Research 211–240 of 698
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Granzyme B in Autoimmune Skin Disease
- Impact of Vitamin D on Immunopathology of Hashimoto’s Thyroiditis: From Theory to Practice
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Dynamic immunomodulatory nanoarchitectonics: Rewiring tissue regenerative microenvironment via intelligent regulation
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Emerging Unconventional Therapies for Alopecia Areata
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Depressive Disorder and Dermatological Autoimmune Diseases
- Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Metabolic Syndrome and Skin Diseases